PFIZER INC Q3 2025 Filing

Filed November 13, 2025

Portfolio Value

$437.5B

Holdings

21

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
BNTXBIONTECH SE
1,658,361$163.5B37.39%
2
ORICORIC PHARMACEUTICALS INC
5,376,344$64.5B14.75%
3
TRMLTOURMALINE BIO INC
1,272,214$60.8B13.91%
4
ARVNARVINAS INC
3,457,815$29.5B6.73%
5
ALLOALLOGENE THERAPEUTICS INC
22,032,040$27.3B6.25%
6
CELCCELCUITY INC
349,406$17.3B3.95%
7
PYXSPYXIS ONCOLOGY INC
7,032,770$15.6B3.57%
8
WVEWAVE LIFE SCIENCES LTD
1,875,000$13.7B3.14%
9
ZURAZURA BIO LTD
2,970,022$12.9B2.94%
10
CRBUCARIBOU BIOSCIENCES INC
4,690,431$10.9B2.50%
11
BHVNBIOHAVEN LTD
505,645$7.6B1.73%
12
CRDFCARDIFF ONCOLOGY INC
2,411,575$5.0B1.14%
13
SPROSPERO THERAPEUTICS INC
2,362,348$4.4B1.02%
14
ZNTLZENTALIS PHARMACEUTICALS INC
953,834$1.4B0.33%
15
NXTCNEXTCURE INC
157,646$923.8M0.21%
16
ANTXAN2 THERAPEUTICS INC
715,295$908.4M0.21%
17
QTTBQ32 BIO INC
277,777$550.0M0.13%
18
EPIEURESSA PHARMA INC
1,675,000$319.9M0.07%
19
BOLTBOLT BIOTHERAPEUTICS INC
31,305$166.5M0.04%
20
DNAGINKGO BIOWORKS HOLDINGS INC
2,928$42.7M0.01%
21
SENS1GBPSENSEONICS HLDGS INC
43,426$18.9M0.00%